Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations

Partha Sarathi Biswas, Devosri Sen

Open source

DOI
10.1177/2042098620957141
Published
2020-01
Container
Therapeutic Advances in Drug Safety
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/2042098620957141,
  title = {Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations},
  author = {Partha Sarathi Biswas and Devosri Sen},
  year = {2020},
  journal = {Therapeutic Advances in Drug Safety},
  doi = {10.1177/2042098620957141},
  url = {https://doi.org/10.1177/2042098620957141}
}

RIS

TY  - JOUR
TI  - Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations
AU  - Partha Sarathi Biswas
AU  - Devosri Sen
PY  - 2020
JO  - Therapeutic Advances in Drug Safety
DO  - 10.1177/2042098620957141
UR  - https://doi.org/10.1177/2042098620957141
ER  - 

APA

Biswas, P. S., & Sen, D. (2020). Hydroxychloroquine and chloroquine for COVID-19: psychiatric aspects of patient safety considerations. Therapeutic Advances in Drug Safety. https://doi.org/10.1177/2042098620957141

Source records